I agree.... to me ARDS which has it's origins in the lungs - will give Ryoncil the highest chance of having the biggest effect, since the cells are IV administered and go directly there with many of them getting stuck in the lungs - even in the absence of ARDS.
GvHD was a much more complicated beast with the cells needing to migrate out of the blood stream into the gut area, skin etc and organs of the gut which sounds like a more challenging, time consuming task for them.
I would think a headline of - "powerful cure, extremely effective with no side effects, not approved because FDA does not understand how it works or how best to manufacture it"
I couldn't imagine that happening in any version of events for COVID where efficacy is shown.
- Forums
- ASX - By Stock
- MSB
- MSB - Most exciting 6 months
MSB
mesoblast limited
Add to My Watchlist
0.93%
!
$1.63

MSB - Most exciting 6 months, page-614
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.082B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $6.975M | 4.265M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 707 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 7320 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11200 | 1.625 |
11 | 72699 | 1.620 |
1 | 30000 | 1.615 |
7 | 58298 | 1.610 |
3 | 96589 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 7000 | 1 |
1.640 | 17668 | 3 |
1.645 | 7000 | 1 |
1.650 | 37309 | 4 |
1.655 | 40000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online